DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8jjfgq/diabetic) has announced the addition of the "Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015" report to their offering.
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Gastroparesis.
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Clinical Trial Overview of Top Companies
- Evoke Pharma, Inc.
- Rhythm Pharmaceuticals
- Ocera Therapeutics, Inc.
- Ironwood Pharmaceuticals, Inc.
- Theravance, Inc.
- Targacept, Inc.
- GlaxoSmithKline plc
- Alfa Wassermann S.p.A
- Chong Kun Dang Pharmaceutical Corp.
- Axis Clinical Trials
Clinical Trial Overview of Top Institutes / Government
- Dartmouth-Hitchcock Medical Center
- Duke University Medical Center
- Malmo University Hospital
- Qingdao University
- Rabin Medical Center
- University of Calgary
- Vienna General Hospital
- Yokohama City University
For more information visit http://www.researchandmarkets.com/research/8jjfgq/diabetic